Astrazeneca plc ADR [NASDAQ: AZN] stock went on an upward path that rose over 0.41% on Monday, amounting to a one-week price increase of more than 7.63%. Over the last 12 months, AZN stock rose by 2.30%. The one-year Astrazeneca plc ADR stock forecast points
Astrazeneca plc ADR [NASDAQ: AZN] jumped around 0.72 points on Tuesday, while shares priced at $70.85 at the close of the session, up 1.03%. Compared to the average trading volume of 6.17M shares, AZN reached a trading volume of 5586567 in the most recent trading
Astrazeneca plc ADR [NASDAQ: AZN] price plunged by -0.29 percent to reach at -$0.2. The one-year AZN stock forecast points to a potential upside of 11.79. The average equity rating for AZN stock is currently 1.69, trading closer to a bullish pattern in the stock
Astrazeneca plc ADR [NASDAQ: AZN] gained 1.05% or 0.71 points to close at $68.41 with a heavy trading volume of 3924276 shares. The company report on April 5, 2024 at 11:10 PM that ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy
Astrazeneca plc ADR [NASDAQ: AZN] price plunged by -0.37 percent to reach at -$0.25. The company report on April 2, 2024 at 7:00 AM that Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer. Application
Astrazeneca plc ADR [NASDAQ: AZN] gained 2.91% or 1.93 points to close at $68.26 with a heavy trading volume of 8443762 shares. The company report on March 25, 2024 at 7:00 AM that ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with
Astrazeneca plc ADR [NASDAQ: AZN] plunged by -$0.13 during the normal trading session on while it closed the day at $65.73. The company report on March 19, 2024 at 7:00 AM that AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat
Astrazeneca plc ADR [NASDAQ: AZN] slipped around -0.27 points on Tuesday, while shares priced at $67.40 at the close of the session, down -0.40%. The company report on February 26, 2024 at 9:00 AM that Alexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE
Astrazeneca plc ADR [NASDAQ: AZN] surged by $0.46 during the normal trading session on while it closed the day at $65.27. The company report on February 26, 2024 at 9:00 AM that Alexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign. In recognition
Astrazeneca plc ADR [NASDAQ: AZN] surged by $0.4 during the normal trading session on while it closed the day at $66.33. The company report on February 26, 2024 at 9:00 AM that Alexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign. In recognition
© 2024, Powered by Smart TechOne
